Navigation Links
DMC Sinai-Grace Selects Loopback Communications' Readmission Reduction™ Services
Date:10/1/2010

DALLAS, Oct. 1 /PRNewswire/ -- DMC Sinai-Grace Hospital has selected Dallas-based Loopback Communications' technology-leading Readmission Reduction™ solution to support its efforts to reduce readmissions of discharged patients.

"DMC Sinai-Grace is committed to continuous quality improvement and patient outcomes," says Katie Flannigan M. S. PA-C, an administrative director for the hospital and special assistant to the president. "We were one of the first hospitals to participate in the Institute for Healthcare Improvement's (IHI) State Action on Avoidable Rehospitalizations (MI STAAR) initiative. Through the initiative, we have experienced tremendous success in reducing 30-day readmissions for patients with heart failure.  In fact, we were just recognized by the IHI for our achievement in impacting the heart failure readmission rate by 30% this past year.

"Loopback's unique technology-based solutions will help us incorporate best practices for the assessment of individual patient risk for readmission and post-discharge follow-up," explains Flannigan. "By connecting with our patients post discharge on a regular basis, we want to provide support and guidance, along with their physician, so that the patients can manage their conditions at home."

"We are excited to partner with highly-respected DMC Sinai-Grace to improve patient outcomes by working with care coordinators to close the loop with discharged patients," says Neil Smiley, Loopback Communications CEO.

"We are particularly focused on reducing readmissions for several diagnoses," says Mike Prusaitis, CFO of SGH. "We know readmissions add costs to the entire health care system, so, we hope to save money by avoiding these costly, avoidable readmissions."

About DMC Sinai-GraceSinai-Grace Hospital is a full-service hospital serving 214,000 patients annually, with 404 licensed beds, more than 700 physicians, 700 nurses and 1,700 support staff. A teaching facility, the hospital is one of eight operated by the Detroit Medical Center (DMC), and has more than 24 ambulatory sites and surgery centers, including the Lasher and Berry Surgery Centers. Services and capabilities include cardiology, emergency medicine, obstetrics/gynecology, urological services, psychiatry, radiation oncology, gerontology, physical medicine and orthopaedic surgery.  

About Loopback CommunicationsLoopback Communications, based in Dallas, Texas, provides hospitals with reliable, cost-effective, technology-enabled solutions to stay connected with patients after discharge to improve clinical outcomes, reduce readmissions, manage risk and improve patient satisfaction.
Easily integrated with current hospital operations, Loopback's solutions place minimal demands on clinical and IT resources.  For more information, visit www.Loopbackllc.com.  For more information contact:Tom Peck, 214.352.5929www.loopbackllc.comhttp://www.HSCMarketing.com


'/>"/>

SOURCE Loopback Communications
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. GeoVax Labs, Inc. Selects Financial Relations Board as Investor Relations Counsel
2. Genzyme Corporation Selects Diplomat Specialty Pharmacy for 2008 Renagel Medicare Part D Assistance Program
3. Catalyst Biosciences Selects Drug Development Candidate in Factor VIIa Program for Hemophilia
4. CellCyte Genetics Corporation Selects Washington University School of Medicine to Perform Study on CellCytes Glycoprotein Products in Heart Attack Disease Model
5. Radius Selects First Preclinical Candidate From SARM Discovery Program for the Treatment of Muscle Loss and Other Musculoskeletal Conditions
6. Sarah Cannon Research Institute Selects OmniComm Systems Electronic Data Capture Solution, TrialMaster(TM), for Clinical Trials Management
7. Halozyme Therapeutics Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target
8. University of California Los Angeles Selects Velos eResearch
9. Accent on Aesthetics Plastic Surgery Medical Center Selects Artefill to Meet Growing Patient Demand for a Longer Lasting Dermal Filler
10. Amarex Clinical Research Selects OmniComm Systems to Provide eClinical Solutions for Phase III Medical Device Study and Joins OmniComms CRO Preferred Program
11. Impax Pharmaceuticals Selects OmniComm Systems to Provide eClinical Solutions for International Phase III Study in Parkinsons Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
(Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
Breaking Medicine Technology:
(Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased ... Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network ... experience in dermatology, skin cancer , and more. She graduated from the University ...
(Date:7/21/2017)... ... July 21, 2017 , ... How physicians and ... the rise, say researchers presenting their work at the American Orthopaedic Society ... combination of evaluating the patterns of change in concussion symptom presentation, diagnostic tools ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
Breaking Medicine News(10 mins):